Bausch Health Co. Inc. (BHC) Misses Q2 EPS by $1.29

Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of ($0.40), $1.29 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $1.97 billion versus the consensus estimate of $2.03 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2022 revenue of $8.05-8.22 billion, versus the consensus of $8.34 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture downgraded by TD Cowen on AI concerns
• Hermès can regain momentum despite China weakness, Jefferies says